Complete Up To Date Information about Coban / Stafac .
NADA Number: 141-110 | |
| Proprietary Name |
Coban® / Stafac® |
|---|---|
| Sponsor |
Elanco Animal Health, A Division of Eli Lilly & Co. |
| Sponsor Address |
Lilly Corporate Center Room 1-23, 12420 Parklawn Drive Indianapolis, IN 46285 USA |
| Ingredients |
Monensin Virginiamycin |
| Species |
Turkey, growing |
| Routes of Administration |
Per Os |
| Dose Form |
Medicated feed |
| Drug Form |
Type A Medicated Article |
| Dispensing Status |
OTC |
| Withdrawal Time |
Turkey: zero days before slaughter. |
|
Dosage Amount, Indications & Limitations |
558.355 Monensin Specifications: Monensin as the base or the sodium salt, contains a minimum of 90 percent monensin activity derived from monensin A and a minimum of 95 percent derived from monensin A plus B. Approvals for Type A medicated articles Conditions of use: Turkeys (growing) Amount: Monensin, 54 to 90 grams, with virginiamycin, 10 to 20 grams. Indications: For the prevention of coccidiosis caused by Eimeria adenoeides, E. meleagrimitis, and E. gallopavonis, and for increased rate of weight gain and improved feed efficiency in growing turkeys. Limitations: For growing turkeys only. Feed continuously as sole ration. Do not allow horses, other equines, mature turkeys, or guinea fowl access to feed containing monensin. Ingestion of monensin by horses, mature turkeys, and guinea fowl has been fatal. Some strains of turkey coccidia may be monensin tolerant or resistant. Monensin may interfere with development of immunity to turkey coccidiosis. Labeling: The labeling of all formulations containing monensin intended for use in turkeys shall bear the following caution statements: Do not allow horses or other equines access to formulations containing monensin. Ingestion of monensin by equines has been fatal. |
| Tolerances |
Tolerances are established for residues of virginiamycin in uncooked edible tissues at 0.4 part per million (ppm) in kidney, skin, and fat, 0.3 ppm in liver, and 0.1 ppm in muscle in swine. A tolerance for residues of virginiamycin in broiler chickens and cattle is not required.Tolerances are established for residues of virginiamycin in uncooked edible tissues at 0.4 part per million (ppm) in kidney, skin, and fat, 0.3 ppm in liver, and 0.1 ppm in muscle in swine. A tolerance for residues of virginiamycin in broiler chickens and cattle is not required. A tolerance of 0.05 part per million is established for negligible residues of monensin in the edible tissues of cattle and goats. A tolerance for residues of monensin in chickens, turkeys and quail is not needed. |